Does psychological treatment of major depression reduce cardiac risk biomarkers? An exploratory randomized controlled

Frank Euteneuer1,2, Marie Neuert2, Stefan Salzmann2

  • 1Clinical Psychology and Psychotherapy, Department of Psychology, Medical School Berlin, Berlin, Germany.

Insights

Cognitive Behavioral Therapy (CBT) improved heart rate variability (HRV) in patients with Major Depression (MD). Those with more severe depression experienced greater cardiovascular benefits from CBT, suggesting psychological treatments impact cardiac health.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychology

Background:

  • Depression is linked to higher cardiovascular disease (CVD) risk.
  • Elevated biological cardiac risk factors are present in depressed individuals without existing CVD.
  • This study explored the impact of treating Major Depression (MD) on cardiac risk biomarkers.

Purpose of the Study:

  • To determine if treating MD with Cognitive Behavioral Therapy (CBT) improves cardiac risk biomarkers.
  • To investigate if baseline depressive symptom severity influences CBT's treatment effects on cardiovascular health.

Main Methods:

  • Eighty antidepressant-free MD patients were randomized to CBT or a waiting list (WL).
  • Biological outcomes included 24-h, daytime, and nighttime heart rate, heart rate variability (HRV), blood pressure, and inflammatory markers (CRP, IL-6, TNF-α).
  • A control group of 40 non-clinical individuals was included for baseline comparisons.

Main Results:

  • CBT significantly increased overall HRV (24-h and daytime HRV triangular index) compared to WL.
  • Trends showed improvements in 24-h low-frequency HRV and daytime systolic blood pressure with CBT.
  • Depressive symptom severity moderated improvements in heart rate and HRV, with greater effects in more depressed patients. No inflammatory marker changes were observed.

Conclusions:

  • CBT enhances overall HRV in MD patients.
  • Patients with higher initial depressive severity experienced more significant cardiovascular improvements with CBT.
  • These findings suggest psychological interventions may have biological benefits for cardiovascular health in depression, warranting further research.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
92
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
56
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
313
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
247
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
43
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
127